Oncomed Pharma (OMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 37,779 | 24,681 | 31,409 | 17,718 |
| Gross Profit | 37,779 | 24,681 | 31,409 | 17,718 |
| Operating Expenses | 61,678 | 47,050 | 46,649 | 46,255 |
| Operating Income | -23,899 | -22,369 | -15,240 | -28,537 |
| Interest Expense | 0 | 0 | 38 | 118 |
| Other Income | -228 | 134 | 244 | 1,640 |
| Pre-tax Income | -24,127 | -22,235 | -15,034 | -27,015 |
| Income Tax | 1,944 | N/A | N/A | N/A |
| Net Income Continuous | -26,071 | -22,235 | -15,034 | -27,015 |
| Net Income | $-26,071 | $-22,235 | $-15,034 | $-27,015 |
| EPS Basic Total Ops | -1.93 | -21.30 | -15.40 | -30.47 |
| EPS Basic Continuous Ops | -1.93 | -21.30 | -15.40 | -30.49 |
| EPS Diluted Total Ops | -1.93 | -21.30 | -15.40 | -30.47 |
| EPS Diluted Continuous Ops | -1.93 | -21.30 | -15.40 | -30.49 |
| EPS Diluted Before Non-Recurring Items | -1.93 | N/A | N/A | N/A |
| EBITDA(a) | $-22,521 | $-21,074 | $-14,298 | $-25,972 |